CVE-2023-2852

CVE-2023-2852 is a critical-severity vulnerability in Softmedyazilim Selfpatron with a CVSS 3.x base score of 9.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-89.

Key facts

Description

Improper Neutralization of Special Elements used in an SQL Command ('SQL Injection') vulnerability in Softmed SelfPatron allows SQL Injection. This issue affects SelfPatron : before 2.0.

Frequently asked questions

What is CVE-2023-2852?
Improper Neutralization of Special Elements used in an SQL Command ('SQL Injection') vulnerability in Softmed SelfPatron allows SQL Injection. This issue affects SelfPatron : before 2.0.
How severe is CVE-2023-2852?
CVE-2023-2852 has a CVSS 3.x base score of 9.8, rated critical severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2023-2852 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (49th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-2852?
CVE-2023-2852 affects Softmedyazilim Selfpatron. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2023-2852?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.
When was CVE-2023-2852 published?
CVE-2023-2852 was published on 2023-07-10 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Softmedyazilim Selfpatron

All CVEs affecting Softmedyazilim Selfpatron →

Other CWE-89 (SQL Injection) vulnerabilities

Browse all CWE-89 (SQL Injection) vulnerabilities →